Fact CheckerSign in

NCT06207357Completed

Optical Trocar to Create the Pneumoperitoneum in Bariatric Patients

Optical Trocar to Facilitate the Pneumoperitoneum Creation in Bariatric Patients: Our Experience and Systematic Review

Source: ClinicalTrials.gov · Last updated 17 Jan 2024

Brief summary (registry, in English)

Laparoscopic bariatric surgery are becoming the most used procedure to treat the obesity. To facilitate safe initial access to the abdominal cavity, we insert an optical viewing trocar at the left hypocondrium. The aim of this study is to systematically evaluate all published data existing in the literature to analyze the safety of optical trocars in patients undergoing bariatric surgery and to compare these data with our experiences.

Status (registry)
Completed
Study type
Observational
Enrollment
403 (actual)
First submitted
15 Dec 2023
Start date
1 Mar 2017
Primary completion date
30 Nov 2023
Lead sponsor
University of Foggia
Diseases
Obesity
NCT number
NCT06207357

What you commit to

  • Study type: Observational
  • Participants enrolled: 403
  • From 1 Mar 2017 to the primary completion date, 30 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • secondary obesity due to endocrine and psychological disorders

Who the study is looking for

  • BMI\>40 kg/m2 BMI\>35 kg/m2with at least one associated major comorbidity

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Giovanna Pavone
Coordinator of this site? Confirm its status
FoggiaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.